Guideline on dental management of pediatric patients receiving chemotherapy, hematopoietic cell transplantation, and/or radiation

Pediatric Dentistry

Volumn 27, Issue 7, 2005, Pages 170-175

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CHILD; DENTAL CARE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; MOUTH DISEASE; NEOPLASM; PRACTICE GUIDELINE; SKULL IRRADIATION;

ANTINEOPLASTIC AGENTS; CHILD; CRANIAL IRRADIATION; DENTAL CARE FOR CHILDREN; DENTAL CARE FOR CHRONICALLY ILL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; MOUTH DISEASES; NEOPLASMS; TRANSPLANTATION CONDITIONING;

EID: 33644678975     PISSN: 01641263     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Barker GJ. Current practices in the oral management of the patient undergoing chemotherapy or bone marrow transplantation. Support Care Cancer 1999;7:17-20.
2. Sonis S, Kunz A. Impact of improved dental services on the frequency of oral complications of cancer therapy for patients with non-head-and-neck malignancies. Oral Surg Oral Med Oral Pathol 1988;65:19-22.
3. Scully C, Epstein JB. Oral health for the cancer patient. Eur J Cancer 1996; 32:281-292.
4. Toth BB, Martin JW, Fleming TJ. Oral and dental care associated with cancer therapy. Cancer Bull 1991; 43:397-402.
5. th ed. St. Louis Mo: Mosby-Year Book Inc; 1998:644-655.
6. National Institutes of Health, National Cancer Institute. Consensus Development Conference on Oral Complications of Cancer Therapies: Diagnosis, Prevention, and Treatment. National Cancer Institute Monograph No. 9. Bethesda, Md: National Institues of Health; 1990.
7. Epstein JB, Schubert MM. Oral mucositis in myelosuppressive cancer therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 88:273-276.
8. nd ed., Malden, Mass: Blackwell Science, Inc; 1999:751-763.
9. Bavier AR. Nursing management of acute oral complications of cancer. Consensus Development Conference on Oral Complications of Cancer Therapies: Diagnosis, Prevention, and Treatment. National Cancer Institute Monograph No. 9. Bethesda, Md: National Institues of Health; 1990:23-128.
10. Little JW, Falace DA, Miller CS, Rhodus NL. Dental Management of the Medically Compromised Patient. St. Louis, Mo: Mosby;2002:332-416.
11. Semba SE, Mealy BL, Hallmon WW. Dentistry and the cancer patient: Part 2: Oral health management of the chemotherapy patient. Compend 1994;15:1378-1387.
12. nd ed. Philadelphia, Pa: W.B. Saunders Co.;1995:426-454.
13. Borowski B, Benhamou E, Pico JL, et al. Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: A randomised controlled trial comparing two protocols of dental care. Oral Oncol Eur J Cancer 1994;30B:93-97.
14. da Fonseca MA. Pediatric bone marrow transplantation: Oral complications and recommendations for care. Pediatr Dent 1998;20:386-394.
15. da Fonseca MA. Long-term oral and craniofacial complications following pediatric bone marrow transplantation. Pediatr Dent 2000;22:57-62.
16. Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis: recommendations by die American Heart Association. JAMA 1997; 277:1794-1801.
17. Ransier A, Epstein JB, Lunn R, Spinelli J. A combined analysis of a toothbrush, foam brush, and a chlorhexidine-soaked foam brush in maintaining oral hygiene. Cane Nurs 1995;18:393-396.
18. Peters E, Monopoli M, Woo SB, Sonis S. Assessment of the need for treatment of postendodontic asymptomatic periapical radiolucencies in bone marrow transplantation. Oral Surg Oral Med Oral Pathol 1993; 76:45-48.
19. Sheller B, Williams B. Orthodontic management of patients with hematologic malignancies. Am J Orthod Dentof Orthop 1996;109:575-580.
20. Rubenstein EB, Peterson DE, Schubert M, et al. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 2004;100(issue S9):2026-2046.
21. Gotzche PC, Johansen HK. Nystatin prophylaxis and treatment in severely immunocompromised patients. Cochrane Database Syst Rev (2):CD002033, 2002.
22. Amerongen AVN, Veerman ECI. Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies. Support Care Cancer 2003;11:226-231.
23. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348:1681-1691.
24. Dahllof G, Jonsson A, Ulmner M, Huggare J. Orthodontic treatment in long-term survivors after bone marrow transplantation. Am J Orthod Dentof Orthop 2001;120:459-465.